Radical total pelvic exenteration with concomitant right nephrectomy in the management of recurrent endometrioid ovarian adenocarcinoma: A case report and literature review-Reference-Cited by-同舟云学术

Radical total pelvic exenteration with concomitant right nephrectomy in the management of recurrent endometrioid ovarian adenocarcinoma: A case report and literature review

Published:2024-07 Issue:7 Volume:12 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Ramachandran Raghavskandhan¹^ORCID,Nistor Sabina²,Gietzmann William³,Symons Nicholas⁴,Soleymani majd Hooman²⁵^ORCID

Affiliation:

1. Medical Sciences Division University of Oxford Oxford UK

2. Department of Gynaecology Oncology Churchill Hospital, Oxford University Hospitals NHS Foundation Trust Oxford UK

3. Department of Urology Oxford University Hospitals NHS Foundation Trust Oxford UK

4. Department of Colorectal Surgery Oxford University Hospitals NHS Foundation Trust Oxford UK

5. Nuffield Department of Women's and Reproductive Health University of Oxford Oxford UK

Abstract

Key Clinical MessageEndometrioid ovarian adenocarcinoma is a common subtype of epithelial ovarian cancer that can arise on a background of endometriosis. Maximal cytoreductive effort with an aim to remove all macroscopic disease (achieve R0) is the single independent prognostic factor for survival. Complex multidisciplinary surgeries may be required in order to achieve this.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.9148

Reference28 articles.

1. Progression Free Survival, Overall Survival, and Relapse Rate in Endometrioid Ovarian Cancer and Synchronous Endometrial-Ovarian Endometrioid Cancer (SEO-EC): Results from a Large Retrospective Analysis

2. Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis

3. Corrections to “Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”

4. Surgical Management of Recurrent Ovarian Cancer

5. Characterization of ovarian cancer survival by histotype and stage: A nationwide study in Norway